Method and system for preventing migraine headaches, cluster headaches and dizziness
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-009/00
A61K-039/395
C07K-016/28
A61M-031/00
A61K-035/747
A61K-045/06
A61K-031/047
A61K-035/74
A61K-035/741
A61K-039/00
출원번호
US-0384716
(2016-12-20)
등록번호
US-9987224
(2018-06-05)
발명자
/ 주소
Kovarik, Joseph E.
Kovarik, Katherine Rose
출원인 / 주소
Kovarik, Joseph E.
대리인 / 주소
Sheridan Ross P.C.
인용정보
피인용 횟수 :
0인용 특허 :
47
초록▼
A method and system for addressing the avoidance of migraines, cluster headaches and dizziness by adjusting an individual's microbiome, and in particular, to the provision of beneficial oral and gut microbes at particular times to enhance a person's oral health, including through the use of oral str
A method and system for addressing the avoidance of migraines, cluster headaches and dizziness by adjusting an individual's microbiome, and in particular, to the provision of beneficial oral and gut microbes at particular times to enhance a person's oral health, including through the use of oral strips that adhere to surfaces in the oral cavity.
대표청구항▼
1. A method of reducing the likelihood of migraine headaches, comprising: providing to an individual in need thereof a buccal bioadhesive strip, said strip having a first and second side, said first side having a surface comprising a pattern defined by a plurality of spaced apart features each havin
1. A method of reducing the likelihood of migraine headaches, comprising: providing to an individual in need thereof a buccal bioadhesive strip, said strip having a first and second side, said first side having a surface comprising a pattern defined by a plurality of spaced apart features each having at least one microscale dimension and having at least one neighboring feature having a substantially different geometry, wherein an average spacing between adjacent ones of said features is between 0.5 and 5 μm in at least a portion of said surface, the second side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, wherein said strip includes xylitol and at least one encapsulated feature containing a least one bacteria selected from the group consisting of Lachnospira, Veillonella, Faecalibacterium and Rothia, further comprising including on said strip an antibody that selectively inhibits the human calcitonin gene-related peptide (CGRP) receptor. 2. A method of reducing the likelihood of migraine headaches, comprising: providing to an individual in need thereof a buccal bioadhesive strip, said strip having a first and second side, said first side having a surface comprising a pattern defined by a plurality of spaced apart features each having at least one microscale dimension and having at least one neighboring feature having a substantially different geometry, wherein an average spacing between adjacent ones of said features is between 0.5 and 5 μm in at least a portion of said surface, the second side having a bioadhesive that is adapted to bind to a mucosal membrane for at least 1 hour while inside a person's mouth, wherein said strip includes xylitol and at least one encapsulated feature containing a least one bacteria selected from the group consisting of Lachnospira, Veillonella, Faecalibacterium and Rothia, wherein said strip is dissolvable in a person's mouth. 3. The method as set forth in claim 1, wherein said bacteria has one of a pathogenic or toxic element excised using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system. 4. The method as set forth in claim 1, wherein said bacteria is transformed by a CRISPR-Cas system to render said bacteria sensitized to an antibiotic. 5. The method as set forth in claim 1, wherein said bacteria is transformed by a CRISPR-Cas system to render said bacteria able to express aldehyde dehydrogenase. 6. The method as set forth in claim 1, wherein said bacteria is modified by employment of a CRISPR-Cas or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to reduce the expression of an endogenous pathogenic protein. 7. The method as set forth in claim 1, wherein said bacteria is modified by employment of a CRISPR-Cas or Cpf1 system to remove a virulence factor selected from the group consisting of the production of gelatinase and hemolysin, adherence to caco-2 and hep-2 cells, and the capacity for biofilm formation. 8. The method as set forth in claim 2, wherein said bacteria is transformed by a CRISPR-Cas system to render said bacteria able to express aldehyde dehydrogenase. 9. The method as set forth in claim 2, wherein said bacteria is modified by employment of a CRISPR-Cas or a CRISPR from Prevotella and Francisella 1 (Cpf1) system to reduce the expression of an endogenous pathogenic protein. 10. The method as set forth in claim 2, wherein said bacteria is modified by employment of a CRISPR-Cas or Cpf1 system to remove a virulence factor selected from the group consisting of the production of gelatinase and hemolysin, adherence to caco-2 and hep-2 cells, and the capacity for biofilm formation. 11. The method as set forth in claim 2, wherein said bacteria is transformed by a CRISPR-Cas system to render said bacteria sensitized to an antibiotic. 12. The method as set forth in claim 2, wherein said bacteria has one of a pathogenic or toxic element excised using a clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR associated protein (Cas) system.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (47)
Park, Yong Ha; Lee, In-seon; Kim, Hong-ik; Kang, Kook-hee, Acid tolerant .
McKenzie, Gregory; McKenzie, Mary-Jane Lombardo; Cook, David N.; Vulic, Marin; von Maltzahn, Geoffrey; Goodman, Brian; Aunins, John Grant; Henn, Matthew R.; Berry, David Arthur; Winkler, Jonathan, Compositions and methods.
Whitlock, David R., Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same.
Smith, Gary Francis; Cha, Alice Shen; Zheng, Zuoxing; Roman, Michael Gerard; Dias, Benjamin Emanuel, Dairy composition with probiotics and anti-microbial system.
Mills, David A.; Lebrilla, Carlito B.; LoCascio, Riccardo; Ninonuevo, Milady; German, J. Bruce; Freeman, Samara, Human milk oligosaccharides to promote growth of beneficial gut bacteria.
Spilburg Curtis A. (Chesterfield MO) Moore William M. (St. Charles MO), Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives.
Uhari Matti Kalervo,FIX ; Kontiokari Tero Tapani,FIX, Method of treating respiratory infections or complications derived therefrom in humans which includes oral administrati.
Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
Davidson, Robert S.; Kehoe, Gary, Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use.
Mittelmark, Martin; Wolverton, Billy C., Micro-irrigation device, system, and method for plant-based cleaning of indoor air and filter bed bioregeneration.
Brennan, Anthony B; Baney, Ronald H.; Carman, Michelle L.; Estes, Thomas G.; Feinberg, Adam W.; Wilson, Leslie H.; Schumacher, James F., Surface topographies for non-toxic bioadhesion control.
Henn, Matthew R.; von Maltzahn, Geoffrey; D'Onofrio, Anthony Mario; Litcofsky, Kevin Daniel; Berry, David A.; Cook, David N.; Afeyan, Noubar B.; Aunins, John Grant, Synergistic bacterial compositions and methods of production and use thereof.
Kerker,William S.; Paasche,Thomas D.; Bamborough,Dave; Bancino,Randy S.; Horder Koop,Robin; McDonald,Kenneth J.; Parker,John P.; Zevalkink,Claire E., System and method for managing recurring orders in a computer network.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.